Table 3.
Coronary heart disease (CHD) risk factor measures at baseline and after 1 year among 123 employees (St. Louis, MO, USA, 2005–2006).
| Outcome | Worksite Aa (Assessment + Intervention) |
Worksite Ba (Assessment Only) |
P value for change from baseline to 1 year, aggregated across sites |
95% confidence interval for changes from baseline to 1 year between sitesb |
||
|---|---|---|---|---|---|---|
| Baseline | 1 year | Baseline | 1 year | |||
| Heart rate (bpm) | ||||||
| Resting | 73 (11) | 71 (10) | 71 (9) | 69 (10) | 0.12 | (−3.20, 0.38) |
| Post-exercise recovery | 103 (18) | 93 (16) | 94 (14) | 90 (17) | <0.01 | (−9.79, −4.95) |
| Blood pressure (mm Hg) | ||||||
| Systolic | 127 (19) | 121 (16) | 121 (15) | 116 (18) | <0.01 | (−8.24, −2.96) |
| Diastolic | 84 (11) | 77 (9) | 79 (10) | 75 (11) | <0.01 | (−6.62, −3.44) |
| Lipids (mg/dL) | ||||||
| Total cholesterol | 200 (32) | 192 (32) | 199 (40) | 195 (36) | <0.01 | (−10.05, −2.63) |
| HDL-cholesterol | 56 (16) | 62 (18) | 54 (17) | 61 (18) | <0.01 | (5.41, 8.38) |
| LDL-cholesterol | 121 (27) | 106 (26) | 121 (35) | 109 (32) | <0.01 | (−17.03, −10.87) |
| Triglycerides | 116 (62) | 118 (60) | 115 (59) | 122 (63) | 0.29 | (−3.60, 12.10) |
| Total cholesterol: HDL ratio | 3.9 (1.1) | 3.3 (1.0) | 3.9 (1.2) | 3.4 (1.0) | <0.01 | (−0.65, −0.46) |
| Fasting glucose (mg/dL) | 96 (20) | 96 (23) | 92 (17) | 96 (20) | 0.21 | (−0.88, 3.97) |
a
Values represent Mean (SD).
b
Smoking status and use of anti-diabetic, anti-hypertensive, and lipid-lowering drugs were controlled for in the analysis.